1. Home
  2. SNAL vs QNRX Comparison

SNAL vs QNRX Comparison

Compare SNAL & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Snail Inc.

SNAL

Snail Inc.

SELL

Current Price

$2.34

Market Cap

21.2M

Sector

Technology

ML Signal

SELL

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

SELL

Current Price

$3.64

Market Cap

17.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SNAL
QNRX
Founded
2000
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
17.8M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
SNAL
QNRX
Price
$2.34
$3.64
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $20.38
AVG Volume (30 Days)
★ 150.0K
9.3K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 120.00
N/A
EPS
N/A
★ N/A
Revenue
★ $81,225,622.00
N/A
Revenue This Year
$25.62
N/A
Revenue Next Year
$7.81
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.59
$3.25
52 Week High
$21.60
$23.50

Technical Indicators

Market Signals
Indicator
SNAL
QNRX
Relative Strength Index (RSI) 52.03 31.80
Support Level $1.92 N/A
Resistance Level $2.63 $5.18
Average True Range (ATR) 0.31 0.28
MACD 0.03 -0.01
Stochastic Oscillator 46.55 6.03

Price Performance

Historical Comparison
SNAL
QNRX

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: